Colistin Resistance in Aeromonas spp

Int J Mol Sci. 2021 Jun 1;22(11):5974. doi: 10.3390/ijms22115974.

Abstract

The increase in the use of antimicrobials such as colistin for the treatment of infectious diseases has led to the appearance of Aeromonas strains resistant to this drug. However, resistance to colistin not only occurs in the clinical area but has also been determined in Aeromonas isolates from the environment or animals, which has been determined by the detection of mcr genes that confer a resistance mechanism to colistin. The variants mcr-1, mcr-3, and mcr-5 have been detected in the genus Aeromonas in animal, environmental, and human fluids samples. In this article, an overview of the resistance to colistin in Aeromonas is shown, as well as the generalities of this molecule and the recommended methods to determine colistin resistance to be used in some of the genus Aeromonas.

Keywords: Aeromonas; antimicrobial resistance; colistin.

Publication types

  • Review

MeSH terms

  • Aeromonas / drug effects
  • Aeromonas / genetics*
  • Aeromonas / pathogenicity
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Colistin / chemistry*
  • Colistin / therapeutic use
  • Drug Resistance, Bacterial / genetics*
  • Humans
  • Plasmids / drug effects
  • Plasmids / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Colistin